BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2309 related articles for article (PubMed ID: 8188937)

  • 1. Differentiation between malignant melanomas and benign melanocytic nevi by computerized DNA cytometry of imprint specimens.
    Stolz W; Vogt T; Landthaler M; Hempfer S; Bingler P; Abmayr W
    J Cutan Pathol; 1994 Feb; 21(1):7-15. PubMed ID: 8188937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA ploidy and nuclear morphometry for the classification of dysplastic nevi.
    Williams RA; Baak JP; Meijer GA; Charlton IG
    Anal Quant Cytol Histol; 1999 Oct; 21(5):437-44. PubMed ID: 10560527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atypical melanocytic nevi of the genital type with a discussion of reciprocal parenchymal-stromal interactions in the biology of neoplasia.
    Clark WH; Hood AF; Tucker MA; Jampel RM
    Hum Pathol; 1998 Jan; 29(1 Suppl 1):S1-24. PubMed ID: 9445124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Grading melanocytic dysplasia in paraffin wax embedded tissue by the nucleic acid index.
    Berman DM; Wincovitch S; Garfield S; Romeo MJ
    J Clin Pathol; 2005 Nov; 58(11):1206-10. PubMed ID: 16254113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multivariate DNA cytometry discriminates between Spitz nevi and malignant melanomas because large polymorphic nuclei in Spitz nevi are not aneuploid.
    Vogt T; Stolz W; Glässl A; Abmayr W; Hohenleutner U; Schmoeckel C; Schiffner R; Landthaler M
    Am J Dermatopathol; 1996 Apr; 18(2):142-50. PubMed ID: 8739988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. α-Methylacyl-coenzyme A racemase (AMACR, p504s) is a marker to distinguish malignant melanomas from dysplastic nevi and melanocytic nevi.
    Abbas M; Ploch EM; Wehling J; Schipper E; Janciauskiene S; Kreipe HH; Jonigk D
    Tumour Biol; 2014 Dec; 35(12):12015-20. PubMed ID: 25149154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IMP-3 EXPRESSION IN BENIGN MELANOCYTIC NEVI, DYSPLASTIC NEVI AND MALIGNANT MELANOMA: PRELIMINARY FINDINGS IN BULGARIAN PATIENTS.
    Chokoeva AA; Ananiev J; Wollina U; Tana C; Lotti T; Cardoso JC; Tchernev G
    J Biol Regul Homeost Agents; 2015; 29(3):695-9. PubMed ID: 26403409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Dysplastic melanocytic nevus].
    Salava A; Ranki A; Saksela O
    Duodecim; 2010; 126(21):2492-501. PubMed ID: 21171474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of DNA ploidy and degree of DNA abnormality in benign and malignant melanocytic lesions of the skin using video imaging.
    Pilch H; Günzel S; Schäffer U; Tanner B; Heine M
    Cancer; 2000 Mar; 88(6):1370-7. PubMed ID: 10717619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of image analysis with flow cytometry for DNA content analysis in pigmented lesions of the skin.
    Sangueza OP; Hyder DM; White CR; Pallander J; Perkins M; Remple N; Bakke A
    Anal Quant Cytol Histol; 1992 Feb; 14(1):55-9. PubMed ID: 1558616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Digital computer analysis of dermatoscopical images of 260 melanocytic skin lesions; perimeter/area ratio for the differentiation between malignant melanomas and melanocytic nevi.
    Fikrle T; Pizinger K
    J Eur Acad Dermatol Venereol; 2007 Jan; 21(1):48-55. PubMed ID: 17207167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nuclear parameters in the superficial and deep portion of melanocytic lesions--a morphometrical investigation.
    Smolle J; Soyer HP; Juettner FM; Hoedl S; Kerl H
    Pathol Res Pract; 1988 Jun; 183(3):266-70. PubMed ID: 3420029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Common acquired melanocytic nevi, melanocytic dysplasia and malignant melanoma. A morphometric study.
    Santucci M; Urso C; Giannini A; Bondi R
    Appl Pathol; 1989; 7(2):111-5. PubMed ID: 2730799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AgNORs in benign, dysplastic, and malignant melanocytic skin lesions.
    Howat AJ; Wright AL; Cotton DW; Reeve S
    Am J Dermatopathol; 1990 Apr; 12(2):156-61. PubMed ID: 2331050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of fluorescence in situ hybridization as a diagnostic tool in melanocytic lesions, using paraffin wax-embedded tissues and imprint-cytology specimens.
    Abásolo A; Vargas MT; Ríos-Martín JJ; Trigo I; Arjona A; González-Cámpora R
    Clin Exp Dermatol; 2012 Dec; 37(8):838-43. PubMed ID: 22731835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dysplastic melanocytic nevi of the lower leg: sex- and site-specific histopathology.
    Coras B; Landthaler M; Stolz W; Vogt T
    Am J Dermatopathol; 2010 Aug; 32(6):599-602. PubMed ID: 20534984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Thermographic examination of cutaneous melanocytic nevi].
    Mikulska D
    Ann Acad Med Stetin; 2009; 55(1):31-8; discussion 38. PubMed ID: 20349589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simulators of malignant melanoma of the skin.
    Cerroni L; Kerl H
    Eur J Dermatol; 1998 Sep; 8(6):388-96. PubMed ID: 9729049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular classification of melanomas and nevi using gene expression microarray signatures and formalin-fixed and paraffin-embedded tissue.
    Koh SS; Opel ML; Wei JP; Yau K; Shah R; Gorre ME; Whitman E; Shitabata PK; Tao Y; Cochran AJ; Abrishami P; Binder SW
    Mod Pathol; 2009 Apr; 22(4):538-46. PubMed ID: 19270649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of melanocytic lesions by DNA image cytometry.
    Schmidt B; Weinberg DS; Hollister K; Barnhill RL
    Cancer; 1994 Jun; 73(12):2971-7. PubMed ID: 8199994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 116.